CD19 and autoimmune thrombocytopenic purpura: At the diagnosis of ITP, NR patients showed lower percentage of IL-10+CD19+ B cells when compared with patients who responded to the treatment ((8.52 ± 2.11)% and (11.29 ± 3.11)%, resp.; P = 0.025).